IDEXX Reference Laboratories
DISCOVER MORE
IDEXX FGF-23 Test
A new method for managing and monitoring phosphorous overload in chronic kidney disease.
Early detection of phosphorous overload and metabolic bone disease in cats with IRIS CKD Stage 1 and Stage 21,2
Enables confident treatment recommendations, such as introducing a phosphate-restrictive diet
Enhanced view of a patient's kidney health — as an addition to IDEXX's suite of kidney health diagnostics, including the IDEXX SDMA Test
References
- Geddes RF, Elliott J, Syme HM. Relationship between Plasma Fibroblast Growth Factor-23 concentration and Survival Time in Cats with Chronic Kidney Disease. J Vet Intern Med. 2015;29:1494-1501.
- Finch NC, Geddes RF, Syme HM, Elliott J. Fibroblast Growth Factor 23 (FGF-23) Concentrations in Cats with Early Nonazotemic Chronic Kidney Disease (CKD) and in Health Geriatric Cats. J Vet Intern Med. 2013;27:227-233